TBPH

Theravance Biopharma Ordinary Shares (TBPH)

About Theravance Biopharma Ordinary Shares (TBPH)

Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.

Details

Daily high
$9.54
Daily low
$9.32
Price at open
$9.32
52 Week High
$10.90
52 Week Low
$7.44
Market cap
464.5M
Dividend yield
0.00%
Volume
268,235
Avg. volume
301,431
P/E ratio
-8.13

Theravance Biopharma Ordinary Shares News

Details

Daily high
$9.54
Daily low
$9.32
Price at open
$9.32
52 Week High
$10.90
52 Week Low
$7.44
Market cap
464.5M
Dividend yield
0.00%
Volume
268,235
Avg. volume
301,431
P/E ratio
-8.13